DPP-4抑制剂对糖耐量异常大鼠血糖的调节  被引量:1

在线阅读下载全文

作  者:王丹萍[1] 韩坤[2] 

机构地区:[1]漯河市中心医院内分泌科,河南462000 [2]漯河医学高等专科学校生理教研室

出  处:《当代医学》2016年第7期4-5,共2页Contemporary Medicine

摘  要:目的观察DPP-4抑制剂用于糖耐量异常的大鼠是否可以逆转糖耐量受损的状况。方法构建糖耐量异常大鼠模型,在此基础上通过测定糖耐量实验前后葡萄糖浓度和胰岛素水平来观察磷酸西格列汀、阿格列汀对糖耐量异常大鼠血糖及胰岛素分泌的调节。结果西格列汀组和阿格列汀组与IGT组空腹血糖和空腹胰岛素水平相比,差异无统计学意义,糖负荷2 h后西格列汀组和阿格列汀组葡萄糖浓度低于IGT组,胰岛素水平高于IGT组,差异有统计学意义(P<0.05),西格列汀组和阿格列汀组与对照组相比无论是葡萄糖浓度还是胰岛素水平,差异均无统计学意义。同时西格列汀组和阿格列汀组相比,差异无统计学意义。结论磷酸西格列汀和阿格列汀均可改善糖耐量异常状态,同时促进糖耐量异常状态下胰岛功能的恢复。并无明显低血糖出现。Objective To observe the DPP 4 inhibitors for abnormal glucose tolerance of impaired glucose tolerance in rats. Methods Build the rat model of abnormal glucose tolerance, and on this basis, through the determination of glucose tolerance of glucose and insulin levels before and after the experiment, to observe Sitagliptin; Alogliptin of glucose tolerance abnormal regulation of blood glucose and insulin secretion in rats. Results Sitagliptin and Alogliptin compared with IGT group of fasting plasma glucose and fasting insulin level has no statistical significance, Sitagliptin and Alogliptin with glucose concentrations below the IGT group, insulin levels higher than the IGT group on Glucose tolerance experiment 2 h, the difference was statistically significant (P〈0.05);~ Sitagliptin and Alogliptin group compared with control group both glucose and insulin levels, there were no statistically significant difference. And Sitagliptin and Alogliptin group has no statistically significant difference. Conclusion Sitagliptin and Alogliptin can improve the glucose tolerance abnormal state, promote the recovery of islet function under the abnormal glucose tolerance, at the same time,there is no obvious hypoglycemic.

关 键 词:糖耐量异常 DPP-4抑制剂 磷酸西格列汀 阿格列汀 

分 类 号:R587.1[医药卫生—内分泌]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象